norm: south texas accelerated research therapeuticsno LEI · no CIKMax severity: Low

Canonical registry

South Texas Oncology and Hematology

ent_51af36b31417ae1f2240c149

Compliance scorecard →View in feed →

Disclosures

1

State AG · 1 jurisdiction

Multi-filing incidents

—

no multi-filing incident in sample

Max affected reported

1

as filed · State AG MT

Leak-site claims

0

none in sample

Identity resolution

Canonical name: South Texas Oncology and Hematology
Normalized: south texas accelerated research therapeutics— dedupe via name-norm; Microsoft / MSFT collapse to one row
GLEIF LEI: No match
SEC EDGAR CIK: None — not an SEC registrant
Domain: None on record

Disclosure history (1)newest first

Montana State AGas reporting2024-09-13
South Texas Oncology and Hematology (STOH) suffered a cybersecurity incident discovered on Feb 15, 2024, where an unauthorized actor accessed its network. START, a related entity, notified clinical trial participants in Utah that their names, DOBs, and health data may have been compromised. Credit monitoring and fraud assistance were offered.